We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
MedTech company Deep Breath Intelligence (DBI) has partnered with HTEC Group and Effectum Medical to expedite meeting software and documentation requirements for In Vitro Diagnostic Directive (IVDD) compliance
TeraRecon, a ConcertAI company, has partnered with US-based Bot Image to add prostate cancer detection and diagnosis feature into the former’s Eureka Clinical AI platform. The Eureka Clinical
Biosensing software company Biospectal has published positive results from a global health study that evaluated the firm’s mobile blood pressure monitoring app, OptiBP, in low-resource urban and rural
Neuralink, a brain-computer interface (BCI) company co-founded by Elon Musk, said that it has received the US Food and Drug Administration (FDA) approval to conduct its first-in-human (FIH)
The American Thoracic Society International Conference took place in Washington, D.C. from 19 to 24 May 2023. During the conference on 23 May, French MedTech Biosency unveiled its
Pearl, the global leader in dental AI solutions, and VisiQuick, one of Europe’s top dental imaging software platforms, today announced that Pearl’s Second Opinion disease detection capabilities are
Medical device maker ZOLL, an Asahi Kasei company, announced that its remedē System has been approved by the US Food and Drug Administration (FDA) for conditional use with
Kytopen, a Massachusetts Institute of Technology (MIT) spin-out and biotechnology company, has started an early access programme for Flowfect Discover to accelerate cell therapy discovery, development, and production.
Artelon Inc., a privately held medical device company, announced today that it closed approximately $20 million in Series B funding, led by Vensana Capital with expected additional participation from existing
Stryker, one of the world’s leading medical technology companies, announced that Early Product Surveillance (EPS) cases utilizing its Q Guidance System with Cranial Guidance Software are underway. The